AGP Picks
View all

Reporting on science and technology news in New Jersey

Provided by AGP

Technology Times New Jersey: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.

Press releases published on May 1, 2026

911inform Launches Safe Entry, a Modern Visitor Management System Built for Real-Time Safety
Nearly 7 in 10 Online Coupon Codes Don’t Actually Work, New Industry Study Finds
SalesCloser Secures U.S. Patent for AI-Powered Conversational Workflow Technology
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Carbonara Announces Run for U.S. Congress in Florida's Redrawn 22nd District
Eupraxia Pharmaceuticals Appoints Dr. Jeymi Tambiah as Chief Medical Officer
Fort Lauderdale Commissioner John Herbst Endorses Michael Carbonara for Congress in FL-22
Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort
Trident Announces Receipt of Nasdaq Determination Letter and Intent to Request Hearing
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Spyre Therapeutics Announces Grants of Inducement Awards
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:

Sign up for:

Technology Times New Jersey

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.